\n \n \n “. concat(self. i18n. t(‘search. voice. recognition_retry’), “\n
The freeze-dried injectables market is expected to be successful at $4 billion through 2028 versus $2. 71 billion in 2021; it is expected to grow at a CAGR of 5. 8% between 2022 and 2028.
New York, Aug. 11, 2022 (GLOBE NEWSWIRE) — Insight Partners has published the latest studies on “Freeze-Dried Injectables Market Forecast to 2028 – Impact of COVID-19 and Global Analysis Across Packaging Type (Single-Use Vials, Care Replacement Point, and Specialty Packaging), Supply Type (Prefilled Diluent Syringes, single-step devices, patented reconstitution devices, and multi-stage devices), indication (metabolic and oncological conditions, infectious diseases, autoimmune, and other diseases), and end-user (hospitals, ambulatory surgery centers, specialty clinics, and others),” the expansion of the global freeze-dried injectables market is driven through the developing call for contract study production and expansion of pharmaceutical product approvals.
Request a PDF pattern brochure on the duration of the freeze-dried injectables market – Impact of COVID-19 and global research with strategic advancements in: https://www. theinsightpartners. com/pattern/TIPRE00004411
Market value in
2. 71 billion US dollars in 2021
Market length by
US$4 billion through 2028
Growth rate
CAGR of 5. 8% from 2022 to 2028
Forecast period
2022-2028
Reference year
2021
Number of pages
200
# of tables
112
Number of charts and figures
84
Historical knowledge available
Yes
Segments covered
Type of packaging, delivery, indication and end user
Regional
North America; Europe ; Asia-Pacific; Latin America; AEM
Country scope
United States, United Kingdom, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Coverage of the report
Revenue forecasts, rankings, competitive landscape, expansion drivers and trends
Global Freeze-Dried Injectables Market: Competitive Landscape and Key Developments
Baxter; nipro; Curia Global, Inc. ; Recipharm AB; Vetter Pharma; Jubilant HollisterStier LLC (Jubilant Pharma Limited); Aristofarma Ltd. ; CordenPharma International; Credencia MedSystems, Inc. ; and S. G. Biopharm Pvt. are among the leading corporations operating in the global freeze-dried injectable market. These players aim to expand, diversify their presence in the market and gain a new visitor base, thus taking advantage of existing opportunities.
Advance Purchase Request: https://www. theinsightpartners. com/inquiry/TIPRE00004411
In May 2022, Jubilant HollisterStier LLC entered into a $149. 6 million cooperation agreement with the Army Contracts Command, in coordination with the Executive Office of the Joint Chemical, Biological, Radiological and Nuclear Defense Program (JPEOCBRND) on behalf of the Biomedical Advanced Research and Development Authority (BARDA), within the U. S. Department of Health and Human Services. USA The U. S. Bailout Effortproduction facility in Spokane, Washington.
In April 2022, Recipharm AB acquired Arranta Bio Advanced Therapy CDMO and Vibalogics Virotreatment CDMO. The acquisitions reflect Recipharm’s strategy for its presence in the biologics market, with a specific focus on the manufacture of new ATMP (advanced treatment drugs) drugs. The acquisitions also allow Recipharm to identify a strong foundation in the United States, with services in Boxborough, MA, and provide a platform from which to perform its functions in new biological modalities.
In March 2022, Curia announced a cooperation agreement with the Biomedical Advanced Research and Development Authority (BARDA), which is part of the Health and Human Services Decomposer (HHS) workplace of the Undersecretary for Preparedness and Response (ASPR), the Ministry of the Executive Office of the Joint Defense Program for Chemical Defense, Biological, Radiological and Nuclear (JPEO-CBRND) and U. S. Army Contract CommandThe U. S. Department of Homeland Security for Injection Drug Production is high-speed filling and finishing vials, adding Biosafety Level 2 (BSL-2) containment at Curia’s existing facility in Albuquerque, New Mexico. Curia also self-finances two freeze dryers for the high-speed filling and finishing line and an insulated flexible filling system line for vials, syringes and cartridges for complex treatments in small batches.
I have a question? Talk to the analyst: https://www. theinsightpartners. com/speak-to-analyst/TIPRE00004411
In February 2022, CordenPharma announced the final touch of the acquisition of 3 Vifor Pharma production sites, which will eventually be renamed Corden Pharma Friborg S. A. (including its Ettingen branch) in Switzerland, and Corden Pharma Lisboa S. A. In Portugal. Acquired pharmaceutical sites have a well-trained workforce with cultural adequacy, infrastructure and a strong compliance record. The opportunity aligns well with CordenPharma’s strategy to expand its CDMO capabilities.
In 2021, North America ruled the global freeze-dried injectables market. The United States has the largest market share in the region. The market expansion is attributed to the expansion of healthcare spending, the expansion of generic pharmaceutical production, and the expansion of government aid to pharmaceutical and biopharmaceutical industries. In addition, the increasing emergence of chronic and acute diseases has indirectly helped the expansion of the market.
In addition, the increasing demand for freeze-dried injectables for safe packaging and extended shelf life, the accumulation in pharmaceutical production due to the COVID-19 pandemic, and the accumulation in studies and progress in the healthcare sector are expected to drive the expansion of the market. In addition, the expansion of the pharmaceutical industry in Mexico is expected to drive market expansion opportunities during the forecast period.
Growing demand for contract production services:
Freeze-drying, or freeze-drying, is composed of the sublimation of ice crystals into steam. Lyophilization is a procedure based on negative temperatures, the activity and stability of the product, as well as active ingredients that are preserved restricting any damage to the product and avoiding any degradation of the molecules. Therefore, freeze-drying is popular in the pharmaceutical and diagnostic sectors. The higher quality and extended shelf life of freeze-dried injectable drugs have created expansion opportunities for brands to implement the freeze-drying procedure in product manufacturing. Manufacturing and contract studios are in high demand, offering freeze-dried injectable drugs to deliver high-quality products to end users.
Take advantage of lucrative discounts on studies on the “freeze-dried injectable market”: https://www. theinsightpartners. com/discount/TIPRE00004411
In addition, many pharmaceutical corporations are refocusing on their core capabilities, such as studies and progression, resulting in divestments of in-house production capabilities, which is driving the call for contract studies (CRAM) for production. In addition, CSAMs play a very important role in mitigating the threat of source shortages by providing more sites to pharmaceutical corporations with multi-site source methods and backup capabilities. For example, in 2019, Samsung Biologics and GI Innovation signed a contract for immunochemotherapy. As a component of the agreement, Samsung Biologics provided everything from the progression of the mobile line to the production of Phase I pharmacological substances.
In addition, the benefits presented through freeze-dried injectables, such as transit and extended time in the pharmaceutical garage, have increased the adoption of the freeze-drying strategy by many corporations around the world.
Global Freeze-Dried Injectables Market: Segmental Overview
Based on packaging type, the global freeze-dried injectables market is segmented into single-use vials, point-of-care reconstitution, and special packaging. The single-use vial segment had the highest market share in 2021. The segment is expected to record the highest CAGR of the forecast period.
Based on delivery type, the global freeze-dried injectables market is segmented into prefilled diluent syringes, single-step devices, proprietary reconstitution devices, and multi-step devices. The prefilled diluent syringes segment occupied the largest share of the market in 2021 and is expected to record the highest CAGR of the forecast period.
On the basis of indications, the global freeze-dried injectables market is segmented into metabolic and oncological situations, infectious diseases, autoimmune diseases, and others. The metabolic and oncology situations segment had the highest market share in 2021 and is expected to record the highest CAGR in the forecast period.
According to end user, the global freeze-dried injectables market is segmented into hospitals, ambulatory surgery centers, specialty clinics, and others. To log in to the highest CAGR on the market, enter the forecast period.
Purchase a premium copy of the Freeze-Dried Injectables Market Expansion Report (2022-2028) at: https://www. theinsightpartners. com/buy/TIPRE00004411
The COVID-19 pandemic has put fitness systems to the test around the world. To lessen the threat of transmission of the virus to patients and in-office fitness staff, elective surgeries and preventive visits, such as annual medical exams, were postponed. personal visits were switched to telemedicine visits where possible. Many patients also began to avoid visits because they did not need to leave their homes and were under threat of exposure. However, the demand for freeze-dried injectables has increased worldwide. due to its various benefits, adding superior stability, simple transport and simple storage. In addition, the increasing occurrence of cancer, metabolic disorders, autoimmune diseases, and infectious diseases would create many opportunities for the expansion of the freeze-dried injectables market during the forecast period. Thus, the COVID-19 pandemic has had a positive effect on the expansion of the global market.
Examine Adjacent Reports: Freeze-Drying Services Market Forecast for Biopharmaceuticals to 2027: Covid-19 Impact and Global Analysis Across Service Type (Product Development and Cycles, Clinical Manufacturing, Commercial Manufacturing, Lyophilization Analytical Services), End User (Pharmaceutical and Biotechnology) Companies, Research Institutes, Others), and Geography
Freeze-drying market forecast till 2028: IMPACT OF COVID-19 and general studies through application (antibiotics, bacteria, vaccines, hormones, vitamins, liposomes, liver extracts, radioimmunoassays, plasma fractions, antibodies); End user (pharmaceutical companies, study institutes, personal laboratories)
Freeze Dryers/Freeze-Drying Appliances Market Forecast till 2028: Impact of COVID-19 and Global Research through (Tray Freeze Dryers, Collector Freeze dryers, and Rotary Freeze Dryers/Housing Freeze Dryers), Operational Scale (Industrial Scale Freeze Dryers, Pilot Scale Lyophilizers and Laboratory Scale Freeze Dryers), Application (Medical, Pharmaceutical, Biotechnology, and Other Applications), and Geography
Gamma Globulin Market Forecast to 2028: Covid-19 Impact and Overall Research Across Product Type (Injection, Freeze-Dried Powder); Application (remedy of neurological and neuromuscular diseases, remedy of diseases of the central nervous system, remedy of diseases of peripheral nerves, remedy of diseases of the neuromuscular junction and muscles); and Geography
Doxorubicin Market Forecast till 2028: COVID-19 Impact and Global Analysis Through Drug Formulation (Freeze-Dried Powder and Doxorubicin Injection), Application (Breast Cancer, Kidney Cancer, Liver Cancer, Sarcoma, Ovarian Cancer, Lung Cancer, Leukemia, Multiple Myeloma), and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)
Injectable Drugs Distribution Market Forecast till 2028 – Impact of Covid-19 and Overall Analysis – By Product Type (Formulation and Devices); Application (autoimmune diseases, oncological disorders, hormonal disorders, orphan diseases and others); End user (home care, outpatient care, doctors’ offices and others)
Sterile Injectable Drugs Market Forecast to 2028: COVID-19 Impact and Global Analysis Across Applications (Cancer, Diabetes, Cardiovascular Disease, Musculoskeletal, CNS, Infections, Others)
Long-acting injectable drugs market forecast till 2028: IMPACT OF COVID-19 and global analysis across type (first generation and second generation); End use (schizophrenia, contraception, HIV and others) and geography
Injectable Cement Market Forecast till 2028: Impact of COVID-19 and Overall Research Across (Low Viscosity Cements, Medium Viscosity Cements, High Viscosity Cements); Applications (periprosthetic fractures, pelvic fractures, others) and geography
Botox Injection Market Forecast till 2028: Covid-19 Impact and Overall Analysis Across Type (50U, 100U, Others); Application (medical, cosmetic) and geography
About Us: Insight Partners is a unique provider of actionable intelligence studies services. We, our clients, locate answers to your study desires through our syndicated studies and consulting services. We specialize in industries such as semiconductors and electronics, aerospace and defense, automotive, and transportation. , biotechnology, fitness informatics, production and construction, medical devices, technology, media and telecommunications, chemicals and materials.
Contact Us: If you have any questions about it or would like more information, please contact us:
Contact Person: Sameer Joshi Email: sales@theinsightpartners. com Phone: 1-646-491-9876 Press Release: https://www. theinsightpartners. com/pr/lyophilized-injectable-drugs-market